A dysregulation of the PI3K-AKT pathway is known for several disorders of the central nervous system such as Parkinson’s disease (Khwanraj et al., 2016), ischemic brain injury (Zhang et al., 2015) as well as epilepsy (Roy et al., 2015). This evidence concerns the gene AKT1 and epilepsy.